Literature DB >> 9505894

Hepatic histology in hepatitis C virus carriers coinfected with hepatitis G virus.

J Petrik1, L Guella, D G Wight, G M Pearson, J Hinton, H Parker, J P Allain, G J Alexander.   

Abstract

BACKGROUND: A novel flavivirus has been described recently and designated hepatitis G virus (HGV). The virus is transmitted by the parenteral route but it is uncertain whether it is associated with chronic liver disease because liver biopsy is difficult to justify in this group. AIMS: To examine histological features of liver biopsy in patients infected with hepatitis C virus (HCV) according to the presence or absence of HCV and HGV RNA.
METHODS: One hundred and thirty one consecutive HCV carriers undergoing staging liver biopsy were studied retrospectively. In each, HCV RNA and HGV RNA were detected by reverse transcription polymerase chain reaction on serum samples collected at the time of biopsy. The presence of each RNA was correlated with histological features blind to the RNA results; individual histological features of inflammation or fibrosis were scored separately.
RESULTS: Nineteen patients were positive for both HGV and HCV RNA in serum, 91 were positive for HCV RNA alone, two were positive for HGV RNA alone, and 19 were negative for both RNA species. Neither age nor sex differed between the groups; a greater proportion of intravenous drug users were HGV RNA positive, but this was not statistically significant. There was no effect of HGV coinfection on the stage of fibrosis or any other histological parameter except steatosis; patients with HCV and HGV RNA had a higher mean score for fat than those patients with HCV RNA alone (p < 0.05).
CONCLUSIONS: HGV coinfection has no important effects on histological features in chronic HCV carriers. It is unlikely that HGV infection causes chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505894      PMCID: PMC1726944          DOI: 10.1136/gut.42.1.103

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  Importance of age in chronic hepatitis C virus infection.

Authors:  V Wong; S Caronia; D Wight; C R Palmer; J Petrik; P Britton; G J Alexander
Journal:  J Viral Hepat       Date:  1997-07       Impact factor: 3.728

Review 2.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

3.  Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis.

Authors:  A S Muerhoff; T P Leary; J N Simons; T J Pilot-Matias; G J Dawson; J C Erker; M L Chalmers; G G Schlauder; S M Desai; I K Mushahwar
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 4.  Classification of chronic hepatitis: diagnosis, grading and staging.

Authors:  V J Desmet; M Gerber; J H Hoofnagle; M Manns; P J Scheuer
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

5.  GBV-C in the aetiology of fulminant hepatitis.

Authors:  J H Kao; P J Chen; D S Chen
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

6.  GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulin.

Authors:  C M Nübling; J Lŏwer
Journal:  Lancet       Date:  1996-01-06       Impact factor: 79.321

7.  Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology.

Authors:  M Yoshiba; H Okamoto; S Mishiro
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

8.  Identification of two flavivirus-like genomes in the GB hepatitis agent.

Authors:  J N Simons; T J Pilot-Matias; T P Leary; G J Dawson; S M Desai; G G Schlauder; A S Muerhoff; J C Erker; S L Buijk; M L Chalmers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

9.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  4 in total

1.  Immunoreactivity to putative B-cell epitopes of hepatitis G virus polyprotein in viremic and nonviremic subjects.

Authors:  P Toniutto; C Fabris; F Barbone; S G Tisminetzky; D Liani; T Galai; G Barillari; F Biffoni; V Gasparini; M Pirisi
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 2.  GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease.

Authors:  M Sathar; P Soni; D York
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

3.  A novel genotype of GB virus C: its identification and predominance among injecting drug users in Yunnan, China.

Authors:  Yue Feng; Wenhua Zhao; Yuemei Feng; Jiejie Dai; Zheng Li; Xiaoyan Zhang; Li Liu; Jie Bai; Huatang Zhang; Ling Lu; Xueshan Xia
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

4.  GB Virus C infection in Patients With HIV/Hepatitis C Virus Coinfection: Improvement of the Liver Function in Chronic Hepatitis C.

Authors:  Yue Feng; Li Liu; Yue-Mei Feng; Wenhua Zhao; Zheng Li; A-Mei Zhang; Yuzhu Song; Xueshan Xia
Journal:  Hepat Mon       Date:  2014-03-03       Impact factor: 0.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.